Coyote Bioscience USA
Coyote Bioscience is dedicated to making break-through innovations in molecular diagnostics that brings complex clinical testing directly to the patient. Coyote offers completed point-of-care molecular diagnostic solutions by providing both devices and consumables. In 2013, Coyote developed its break-through one-step Molecular Diagnostic Method based on direct QPCR technology, and this system not only have PCT patents worldwide, but also can be put into over 20 applications in infectious diseases testing, personalized medicine and cancer screening. In 2015, Coyote Mini8 Real Time PCR system has been adopted in the list of WHO Emergency Quality Assurance Mechanism(EQAM) for Ebola virus disease testing in Africa. In 2015, Coyote successfully developed InstantGene, the fastest and simplest gene sensor in the world, which can get Molecular Diagnostic Result from a drop of blood in 10 min. The mission of Coyote is to let everyone benefit from Molecular Diagnostics, and the Coyote Team is working day and night to make it happen in the near future.
About Coyote Bioscience USA
Estimated Revenue
$10M-$50MEmployees
51-250Category
Industry
BiotechnologyLocation
City
AlamedaState
CaliforniaCountry
United StatesCoyote Bioscience USA
Find your buyer within Coyote Bioscience USA